Knowledge and attitudes towards HIV vaccines among Soweto adolescents

被引:22
作者
De Bruyn G. [1 ]
Skhosana N. [1 ]
Robertson G. [1 ]
McIntyre J.A. [1 ]
Gray G.E. [1 ]
机构
[1] Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg
关键词
Sexual Debut; Trial Participation; Clinical Trial Participation; Vaccine Clinical Trial; Adolescent Participation;
D O I
10.1186/1756-0500-1-76
中图分类号
学科分类号
摘要
Background: To explore adolescent HIV risk perception, HIV vaccine knowledge, willingness to participate in future HIV vaccine clinical trials, and the factors that influence willingness to participate among high school students in Soweto, South Africa, we recruited school-going youth through randomly selected local high schools. All pupils within the selected schools from whom parental consent and child assent could be obtained were eligible for participation. A self-administered, facilitated questionnaire was completed by all participants. Findings: Perception of adolescent HIV risk was high. Some misconceptions regarding vaccine research were common, particularly regarding placebo and potential eligibility criteria for prophylactic vaccine trials. Of 240 responses to the willingness item, 84 (35%) indicated they were "probably willing" and 126 (52.5%) that they were "definitely willing to participate". There were no significant differences in willingness by gender, age, school grade, or institution. Factors that were rated as "very important" in determining willingness included receiving current information about HIV research [n = 201 (88.9%)], doing something to honour people who have HIV or have died of AIDS [n = 168 (70.9%)], getting free counselling and testing [n = 167 (70.5)], that participants may receive some protection against HIV infection from the vaccine [n = 160 (70.2%)], and improving motivation to avoid risky behaviour [n = 134 (59%)]. Conclusion: Soweto school-going youth report high degrees of willingness to participate in HIV vaccine trials. This may be related to the high levels of adolescent HIV risk perception. Whether hypothetical willingness translates to participation will await data from adolescent HIV vaccine trials. © 2008 de Bruyn et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 18 条
[1]  
AIDS Epidemic Update: December 2005, (2005)
[2]  
McClure C.A., Gray G., Rybczyk G.K., Wright P.F., Challenges to conducting HIV preventative vaccine trials with adolescents, Journal of Acquired Immune Deficiency Syndromes (1999), 36, 2, pp. 726-733, (2004)
[3]  
Jaspan H.B., Bekker L.G., Grant C.J., Slack C., Protecting South Africa's children: Giving them our best shot, South African Journal of Science, 36, (2005)
[4]  
Shisana O., Simbayi L.C., Bezuidenhout F., Brookes H.J., Chauveau J., Colvin M., Connolly C., Ditlopo P., Kelly K., Moatti J.P., Loundou A.D., Parker W., Richter L., Schwabe C., Toefy Y., Van Zyl J., Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV Prevalence, Behavioural Risks and Mass Media: Household Survey 2002, (2002)
[5]  
Pettifor A.E., Rees H.V., Kleinschmidt I., Steffenson A.E., MacPhail C., Hlongwa-Madikizela L., Vermaak K., Padian N.S., Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey, AIDS, 19, 14, pp. 1525-1534, (2005)
[6]  
Pettifor A.E., MacPhail C., Bertozzi S., Rees H., The challenge of evaluating a national HIV prevention program: The case of loveLife, South Africa, Sex Transm Infect, (2007)
[7]  
Sayles J.N., Pettifor A., Wong M.D., MacPhail C., Lee S.J., Hendriksen E., Rees H.V., Coates T., Factors associated with self-efficacy for condom use and sexual negotiation among South african youth, Journal of Acquired Immune Deficiency Syndromes (1999), 43, 2, pp. 226-233, (2006)
[8]  
Simbayi L.C., Kalichman S.C., Jooste S., Cherry C., Mfecane S., Cain D., Risk factors for HIV-AIDS among youth in Cape Town, South Africa, AIDS Behav, 9, 1, pp. 53-61, (2005)
[9]  
Jaspan H.B., Gray G.E., Robinson A.K., Coovadia H.M., Bekker L.G., Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa, South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 95, 9, pp. 685-687, (2005)
[10]  
Koblin B.A., Heagerty P., Sheon A., Buchbinder S., Celum C., Douglas J.M., Gross M., Marmor M., Mayer K., Metzger D., Seage G., Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States, AIDS, 12, 7, pp. 785-793, (1998)